Last October, The World Bladder Cancer Patient Coalition joined for the first time the World Cancer Congress 2022. Organized in Geneva, Switzerland, by the Union for International Cancer Control (UICC), the Congress welcomed 2000+ participants from over 120 countries for the first time since 2018.
WBCPC Executive Director, Alex Filicevas, joined a digital panel discussion titled “Empowering genitourinary cancer patients to become their own best advocates.” Organized by the European Association of Urology and co-developed by WBCPC,
At the World Bladder Cancer Patient Forum, Stephen Head, Senior Director of Patient Partnerships at Astellas Pharma Europe joined the panel discussion on taking bladder cancer patients’ voice forward, bringing an industry perspective to the table.
He discussed the importance of raising our voice as a global community as worldwide, over 570,000 people are diagnosed with bladder cancer and 1.7 million people find themselves living with the condition. He pointed out that there is an urgent need to raise awareness for people who are at risk of bladder cancer,
On December 7, 2022, Alex Filicevas, Executive Director of the World Bladder Cancer Patient Coalition, co-chaired a joint event in the European Parliament on the challenge of urinary problems faced by people living with prostate and bladder cancer.
The event was a collaboration between the European Cancer Organisation, European Association of Urology, European Association of Urology Nurses – EAUN, World Federation of Incontinence and Pelvic Problems,
The World Bladder Cancer Patient Coalition is organizing a policy discussion entitled: “The ‘P’ Word: the challenge of urinary problems in people living with prostate and bladder cancer” together with the European Cancer Organisation, European Association of Urology, European Association of Urology Nurses – EAUN, World Federation of Incontinence and Pelvic Problems, Eurocarers and Europa Uomo.
Our international community met in Paris and virtually for the second World Bladder Cancer Patient Forum. We had the chance to hear from Sarah Collen, EU Policy Manager at the European Association of Urology,discussing the importance of building partnerships at both European and International levels and how policy initiatives such as Europe’s Beating Cancer Plan, Horizon Europe and EU cancer mission are a call to action.
The second World Bladder Cancer Patient Forum brought together our bladder cancer community in Paris and virtually. This year’s Forum was a milestone event for our international community. Both because we got to get together for the first time in person and as we shared advance insights from our first bladder cancer patient and caregiver survey.
Dr Ignacio Durán, medical oncologist and Coordinator of the Genitourinary Oncology Programme at the Medical Oncology Department of the Hospital Universitario Marques de Valdecilla,
Alex Filicevas, Executive Director of the World Bladder Cancer Patient Coalition, joined a panel discussion at The Economist’s 8th Annual World Cancer Series: Europe, which took place in person on November 8 – 9, 2022, in Brussels, Belgium.
The 8th World Cancer Series: Europe 2022 focused on ”innovation, equity and excellence”. It explored different strategies to accelerate innovation, reduce inequities across cancer control in Europe, and what could to done to build towards universally excellent cancer control and cancer outcomes across the continent.
Dr Stephanie Demkiw, co-founder of Bladder Cancer Awareness Australia, co-developed guidelines from a general practice perspective about how to treat haematuria with some of Australia’s top urologists specializing in bladder cancer care.
This helpful resource summarises the aetiology, investigation and management of haematuria in the primary care setting, with a focus on urological assessment and outcomes.
The presence of bladder in the urine may be a singular symptom signalling underlying urological pathology,
